MENDLEIN JOHN has filed 8 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 55000 shares of FATE THERAPEUTICS INC ($FATE) on May 29, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2025 | FATE THERAPEUTICS INC | $FATE | MENDLEIN JOHN | Not found | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 113,685,177 | 9999.99% | 0.05% |
| June 20, 2024 | Omega Therapeutics, Inc. | $OMGAQ | MENDLEIN JOHN | Not found | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 55,154,985 | 9999.99% | 0.05% |
| June 7, 2024 | FATE THERAPEUTICS INC | $FATE | MENDLEIN JOHN | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 98,411,162 | 9999.99% | 0.04% |
| June 6, 2023 | FATE THERAPEUTICS INC | $FATE | MENDLEIN JOHN | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2023 | FATE THERAPEUTICS INC | $FATE | MENDLEIN JOHN | Director | M | Common Stock | 28461 | $1.37 | 311,231.0000 | 0 | 10.07% | 0.00% |
| Jan. 19, 2023 | FATE THERAPEUTICS INC | $FATE | MENDLEIN JOHN | Director | M | Stock Option (Right to Buy) | 28461 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Jan. 11, 2023 | FATE THERAPEUTICS INC | $FATE | MENDLEIN JOHN | Director | P | Common Stock | 88048 | $5.67 | 246,139.0000 | 0 | 55.69% | 0.00% |
| Jan. 13, 2023 | FATE THERAPEUTICS INC | $FATE | MENDLEIN JOHN | Director | P | Common Stock | 36631 | $5.43 | 282,770.0000 | 0 | 14.88% | 0.00% |